Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NVCR
#2070
NovoCure Limited - Ordinary Shares
15.5
5
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.36%
Monthly Change
-11.65%
6 month change
+13.09%
Year Change
+13.09%
Previous Close
16.0
9
Open
15.5
5
Low
15.5
5
High
15.5
5
Volume
143
Markets
US Stock Market
Healthcare
Medical Devices
NVCR
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
102.41 M
104.42 M
105.46 M
107.09 M
109.92 M
113.79 M
115.82 M
Valuation ratios
Enterprise value
17.92 B
8.19 B
7.61 B
1.87 B
3.77 B
1.57 B
2.12 B
Price to earnings ratio
961.33
-134.07
-77.2
-7.38
-19.1
-10.6
-11.38
Price to sales ratio
38.11
14.51
13.22
3.01
5.31
2.2
2.9
Price to cash flow ratio
190.02
93.84
230.95
-20.89
-121.87
-29.4
-72.85
Price to book ratio
39.54
18.92
16.12
4.23
8.92
4.23
1.43
Enterprise value to EBITDA ratio
477.14
-214.58
-91.61
-8.29
-23.3
-11.17
-10.48
Profitability ratios
Return on assets %
0.02
-0.05
-0.08
-0.18
-0.14
-0.17
-0.09
Return on equity %
0.04
-0.14
-0.21
-0.57
-0.47
-0.4
-0.22
Return on invested capital %
105.03
-149.65
-317.14
-702.9
-111.43
-316.69
-125.67
Gross margin %
78.46
78.53
78.64
74.81
77.33
74.54
77.63
Operating margin %
6.15
-8.29
-16.64
-45.72
-28.17
-23.47
-38.73
EBITDA margin %
7.6
-7.14
-15.46
-44.3
-26.72
-21.48
-40.24
Net margin %
4.01
-10.91
-17.2
-40.65
-27.86
-20.79
-40.87
Liquidity ratios
Quick ratio
8.56
7.36
6.82
5.56
1.42
2.71
2.7
Current ratio
8.8
7.53
7
5.78
1.46
2.9
2.9
Inventory turnover
0.02
0.04
0.01
0
0.01
0.08
—
Asset turnover
0.65
0.49
0.46
0.44
0.51
0.64
0.22
Solvency ratios
Debt to assets ratio
0.41
0.49
0.47
0.5
0.08
0.24
0.25
Debt to equity ratio
0.9
1.37
1.28
1.57
0.27
0.57
0.59
Long term debt to total assets ratio
0.41
0.49
0.47
0.5
0.53
0.24
0.25
Long term debt to total equity ratio
0.9
1.37
1.28
1.57
1.82
0.57
0.59
Per share metrics
Operating cash flow per share
0.91
0.8
0.29
-0.69
-0.24
-0.44
-0.24
EBIT per share
0.28
-0.43
-0.86
-2.19
-1.58
-1.38
-1.63
EBITDA per share
0.34
-0.37
-0.79
-2.12
-1.5
-1.26
-1.8
Total debt per share
3.95
5.44
5.4
5.35
6.08
1.75
1.71
Cash per share
7.74
9.07
9.26
8.56
8.9
4.02
3.78
Net current asset value per share
9.18
10.38
10.62
9.72
10.26
5.8
5.53
Tangible book value per share
4.38
3.97
4.22
3.41
3.34
3.05
2.9
Working capital per share
8.14
9
9.1
8.04
3.25
3.8
3.63
Book value per share
4.38
3.97
4.22
3.41
3.34
3.05
2.9
News
NovoCure: 'Buy' TRIDENT Setback And TTFields FDA Decision Q4 2026 (NASDAQ:NVCR)
NovoCure's Cancer Treatment Device Option Pax Gets European Approval
NovoCure: Solid Fundamentals, But TRIDENT Caps Near-Term Upside (NASDAQ:NVCR)
Stocks Sharply Higher as US-Iran Peace Deal Eases Inflation Risks
Stocks Supported as Geopolitical Risks Recede
Stocks Rally as President Trump Signs a Preliminary Deal to End the US-Iran War
Novocure Tumbles After Cancer-Fighting Medical Device Flops In Brain Cancer
Strength Seen in Nurix Therapeutics (NRIX): Can Its 6.8% Jump Turn into More Strength?
International Markets and NovoCure (NVCR): A Deep Dive for Investors
NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry
Two Medical Stocks Skyrocket After Demolishing Views — And One Is About To Break Out
NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates